Israel Englander Verrica Pharmaceuticals Inc. Transaction History

Millennium Management LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$5.32 - $6.79 $438,378 - $559,509	82,402 Added 46.24%	260,614 $1.5 Million
Q1 2023 May 15, 2023	SELL	$2.88 - $8.51 $78,433 - $231,761	-27,234 Reduced 13.26%	178,212 $1.16 Million
Q4 2022 Feb 14, 2023	BUY	$2.09 - $3.39 $274,567 - $445,351	131,372 Added 177.35%	205,446 $565,000
Q3 2022 Nov 14, 2022	SELL	$2.17 - $4.3 $129,462 - $256,538	-59,660 Reduced 44.61%	74,074 $216,000
Q2 2022 Aug 15, 2022	BUY	$1.81 - $8.93 $65,208 - $321,721	36,027 Added 36.87%	133,734 $257,000
Q1 2022 May 16, 2022	BUY	$7.59 - $9.49 $26,466 - $33,091	3,487 Added 3.7%	97,707 $792,000
Q4 2021 Feb 14, 2022	BUY	$9.1 - $13.36 $706,069 - $1.04 Million	77,590 Added 466.57%	94,220 $863,000
Q3 2021 Nov 15, 2021	SELL	$9.55 - $13.96 $2.89 Million - $4.23 Million	-302,922 Reduced 94.8%	16,630 $208,000
Q2 2021 Aug 16, 2021	BUY	$9.77 - $15.33 $2.8 Million - $4.39 Million	286,134 Added 856.23%	319,552 $3.61 Million
Q1 2021 May 17, 2021	SELL	$10.51 - $17.46 $3.17 Million - $5.27 Million	-301,900 Reduced 90.03%	33,418 $506,000
Q4 2020 Feb 16, 2021	SELL	$7.41 - $12.63 $204,893 - $349,232	-27,651 Reduced 7.62%	335,318 $3.86 Million
Q3 2020 Nov 16, 2020	BUY	$6.16 - $10.3 $2.24 Million - $3.74 Million	362,969 New	362,969 $2.81 Million
Q3 2018 Nov 14, 2018	SELL	$13.94 - $19.88 $358,941 - $511,890	-25,749 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$17.5 - $20.34 $450,607 - $523,734	25,749 New	25,749 $508,000

17.4M

6.1K

6.3K

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.